文献速递中药与中成药合理使用中医内科中医骨伤

中药配方颗粒调控信号通路介导疾病机制研究进展

Research advances in the study of traditional Chinese medicine formula granules on signaling pathway-mediated disease mechanisms.
PubMed 文献 · Front Pharmacol · 2025-06-03

本文系统综述中药配方颗粒(TCMFG)通过调控TLR4/NF-κB、MAPK、NLRP3炎症小体、PI3K/Akt/mTOR、Wnt/β-catenin及TGF-β/Smads等信号通路治疗炎症、肿瘤、代谢紊乱、纤维化及骨关节炎等复杂疾病的研究进展。文章指出当前研究面临单成分分析、复方协同机制不清及临床证据不足等挑战,提出未来需整合多组学技术并开展大规模临床试验以推动精准医学应用。

要点

  • 中药配方颗粒经标准化工艺保留活性成分,是其多靶点调控作用的物质基础。
  • TCMFG通过TLR4/NF-κB、MAPK等通路干预炎症、肿瘤及骨关节疾病。
  • 当前研究需解决复方协同机制不清与临床转化证据不足的问题。

核心结论

  • 中药配方颗粒通过调控多条信号通路在炎症、肿瘤、代谢病及骨关节病中展现治疗潜力,但复方协同机制与临床转化证据仍需加强。
  • 未来需整合多组学技术探索复方超分子协同效应,并开展大规模临床试验验证其精准医学价值。

研究设计与样本

  • 本文为综述,系统汇总中药配方颗粒调控信号通路介导疾病机制的研究进展。

主要发现

  • 小檗碱通过抑制TLR4/NF-κB通路减轻急性肺损伤。
  • 川芎来源的四甲基吡嗪通过抑制MAPK信号减轻类风湿关节炎关节破坏。
  • 姜黄素类似物通过PI3K/Akt通路抑制肿瘤代谢重编程。
  • TCMFG在炎症、肿瘤、代谢紊乱、纤维化及骨关节炎、骨质疏松等疾病中通过TLR4/NF-κB、MAPK、NLRP3炎症小体、PI3K/Akt/mTOR、Wnt/β-catenin、TGF-β/Smads等通路发挥调控作用。

临床怎么用

  • 临证可关注中药配方颗粒在炎症、肿瘤、代谢及骨关节疾病中基于信号通路的多靶点调控潜力。
  • 应用时需认识复方协同机制尚不明确,应结合临床证据审慎评估其精准医学定位。

局限性

  • 当前研究多为单成分分析,复方混合物协同机制不清晰。
  • 临床转化应用证据不足,缺乏大规模临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As a modern dosage form of traditional Chinese medicine, Traditional Chinese Medicine Formula Granules (TCMFG) maximally retains active metabolites through standardized production processes, including dynamic countercurrent extraction and low-temperature concentration. This serves as a critical material basis for elucidating its multi-target regulatory mechanisms. Recent studies have highlighted the significant potential of TCMFG in treating complex diseases, such as inflammation, tumors, metabolic disorders, fibrosis, and orthopedic conditions like osteoarthritis and osteoporosis, by modulating signaling pathways such as TLR4/NF-κB, MAPK, NLRP3 inflammasome, PI3K/Akt/mTOR, Wnt/β-catenin, and TGF-β/Smads. For example, berberine alleviates acute lung injury by inhibiting the TLR4/NF-κB pathway, while tetramethylpyrazine derived from Ligusticum chuanxiong Hort granules mitigate joint destruction in rheumatoid arthritis by suppressing MAPK signaling. Curcumin analogs inhibit tumor metabolic reprogramming via the PI3K/Akt pathway. Despite these advances, current research encounters challenges, such as single-component analysis, unclear synergistic mechanisms of compound mixtures, and insufficient clinical evidence for translational applications. In the future, integrating multi-omics technologies (e.g., metabolomics, spatial transcriptomics) will be crucial for exploring supramolecular synergistic effects of compound mixtures. Furthermore, large-scale clinical trials are necessary to validate its potential in precision medicine. This article systematically reviews the progress of TCMFG research in signaling pathway-mediated disease mechanisms and outlines future directions to enhance its application in modern precision medicine.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gu ZX, Wang ZH, Zhang XQ, et al. Research advances in the study of traditional Chinese medicine formula granules on signaling pathway-mediated disease mechanisms. Front Pharmacol. 2025. PMID: 40529488. doi:10.3389/fphar.2025.1609211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。